About usSign in
Status
ACTIVE
Global HQ
New York, United States
Countries of investment
  • USA
  • Canada
Investment stages
  • Pre-Seed
  • Seed
  • Series A
Industries
  • Fintech
  • AI
  • Health Tech
  • Blockchain
  • Crypto
About
QED Investors is a premier venture Capital firm specializing in the fintech space, headquartered in Alexandria, Virginia. Founded by Nigel Morris and Frank Rotman, along with Caribou Honig in 2007, the firm leverages deep operational expertise and a commitment to fairness, transparency, and access to financial services. QED invests globally, with notable investments in Credit Karma, Pitzi, NuBank, Guiabolso, and Creditas. The team's 250 combined years of experience and a focus on unit economics drive their strategy. QED supports companies through their entire lifecycle from pre-seed to IPO, providing not just Capital but also extensive strategic and operational support.
Min check size
$250K
Max check size
$5M
Fund size
NPS

Investment Thesis

They invest in pragmatic disruptors who are the future of finance.
Lead investor
Co Invest
Number of exits
Preferred contact method

Portfolio

Tenpoint Therapeutics

Soda Health

Jasper Therapeutics

Tourmaline Bio

Satellos Bioscience

Abdera Therapeutics

Entact Bio

Auron Therapeutics

Boulder Care

Talaris Therapeutics

Elevation Oncology

HilleVax

Ventyx Biosciences

Korro Bio

Icosavax

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp